• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1例患有荨麻疹性血管炎的患者发生了近乎致命的氨苯砜超敏综合征。

A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis.

作者信息

Leslie K S, Gaffney K, Ross C N, Ridley S, Barker T H, Garioch J J

机构信息

Norfolk & Norwich University Hospital, Norwich, UK.

出版信息

Clin Exp Dermatol. 2003 Sep;28(5):496-8. doi: 10.1046/j.1365-2230.2003.01336.x.

DOI:10.1046/j.1365-2230.2003.01336.x
PMID:12950336
Abstract

Dapsone (4,4'-diaminodiphenyl sulphone) is used for a variety of dermatological conditions including immunobullous diseases and urticarial vasculitis. Side-effects are common and include lethargy, headaches, methaemoglobinaemia and haemolysis. Severe adverse effects are rare but the dapsone hypersensitivity syndrome is well recognized. Symptoms include fever, haemolytic anaemia, lymphocytosis and hepatitis. We report a near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis. This diagnosis should be remembered in any patient who becomes unwell whilst taking dapsone.

摘要

氨苯砜(4,4'-二氨基二苯砜)用于多种皮肤病,包括免疫性大疱性疾病和荨麻疹性血管炎。副作用很常见,包括嗜睡、头痛、高铁血红蛋白血症和溶血。严重不良反应很少见,但氨苯砜超敏综合征已得到充分认识。症状包括发热、溶血性贫血、淋巴细胞增多和肝炎。我们报告了1例荨麻疹性血管炎患者发生的近乎致命的氨苯砜超敏综合征病例。对于任何在服用氨苯砜期间出现不适的患者,都应考虑这一诊断。

相似文献

1
A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis.1例患有荨麻疹性血管炎的患者发生了近乎致命的氨苯砜超敏综合征。
Clin Exp Dermatol. 2003 Sep;28(5):496-8. doi: 10.1046/j.1365-2230.2003.01336.x.
2
Severe dapsone hypersensitivity syndrome.严重氨苯砜超敏综合征。
J Investig Allergol Clin Immunol. 2006;16(4):268-70.
3
Dapsone hypersensitivity syndrome with myocarditis.氨苯砜超敏综合征伴心肌炎。
J Assoc Physicians India. 2014 Aug;62(8):728-31.
4
Presumed dapsone-induced drug hypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis.推测为氨苯砜所致药物超敏反应综合征,引发可逆性超敏性心肌炎和甲状腺毒症。
Ann Acad Med Singap. 2006 Nov;35(11):833-6.
5
Case report: dapsone hypersensitivity syndrome associated with treatment of the bite of a brown recluse spider.
Am J Med Sci. 1988 Oct;296(4):270-1. doi: 10.1016/s0002-9629(15)40859-6.
6
[An Antilles fever. Dapsone allergy].[安的列斯群岛热。氨苯砜过敏]
Rev Med Interne. 2001 Jun;22 Suppl 2:250s-252s. doi: 10.1016/s0248-8663(01)83663-8.
7
Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies.二氨苯砜超敏反应综合征伴循环 190kDa 和 230kDa 自身抗体。
Clin Exp Dermatol. 2009 Dec;34(8):e798-801. doi: 10.1111/j.1365-2230.2009.03527.x. Epub 2009 Sep 22.
8
Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis.伴有紫癜的慢性荨麻疹:22例具有荨麻疹性血管炎临床特征患者的前瞻性系列研究中的临床和组织病理学特征谱
J Am Acad Dermatol. 2007 Jun;56(6):994-1005. doi: 10.1016/j.jaad.2006.10.962.
9
Alternative procedure to allow continuation of dapsone therapy despite serious adverse reaction in a case of dapsone-sensitive erythema elevatum diutinum.替代方案可允许继续使用氨苯砜治疗,尽管在一例氨苯砜敏感的持久性隆起性红斑中出现严重不良反应。
Dermatology. 2012;224(2):115-9. doi: 10.1159/000337424. Epub 2012 Apr 12.
10
Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline.
Acta Derm Venereol. 1995 Jan;75(1):54-6. doi: 10.2340/00015555755456.

引用本文的文献

1
Non-leprosy related dapsone hypersensitivity syndrome: A case report and literature review.非麻风相关的氨苯砜超敏反应综合征:一例病例报告及文献综述
Medicine (Baltimore). 2025 Jul 4;104(27):e43073. doi: 10.1097/MD.0000000000043073.
2
Managing Urticarial Vasculitis: A Clinical Decision-Making Algorithm Based on Expert Consensus.荨麻疹性血管炎的管理:基于专家共识的临床决策算法
Am J Clin Dermatol. 2025 Jan;26(1):61-75. doi: 10.1007/s40257-024-00902-y. Epub 2024 Nov 13.
3
Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia.
验证 HLA-B*13:01 作为印度尼西亚麻风病患者中氨苯砜超敏综合征生物标志物的研究。
PLoS Negl Trop Dis. 2020 Oct 16;14(10):e0008746. doi: 10.1371/journal.pntd.0008746. eCollection 2020 Oct.
4
Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy.评估 HLA-B*13:01 前瞻性筛查在预防麻风病患者中发生氨苯砜超敏综合征中的作用。
JAMA Dermatol. 2019 Jun 1;155(6):666-672. doi: 10.1001/jamadermatol.2018.5360.
5
Case report of two cases of fever, rash, and organ involvement during the treatment of leprosy.两例麻风病治疗期间出现发热、皮疹及器官受累的病例报告。
PLoS Negl Trop Dis. 2014 Aug 28;8(8):e3130. doi: 10.1371/journal.pntd.0003130. eCollection 2014 Aug.
6
Dapsone hypersensitivity syndrome: A rare life threatening complication of dapsone therapy.氨苯砜超敏综合征:氨苯砜治疗罕见的危及生命的并发症。
J Pharmacol Pharmacother. 2013 Apr;4(2):158-60. doi: 10.4103/0976-500X.110917.
7
The Dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations.再谈氨苯砜超敏反应综合征:一种具有显著肝肺表现的潜在致命性多系统疾病。
J Occup Med Toxicol. 2006 Jun 6;1:9. doi: 10.1186/1745-6673-1-9.